No Data
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating
Wedbush Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $18
Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From Wedbush
Needham Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $23
Buy Rating Affirmed for Artiva Biotherapeutics Amidst Clinical Advancements and Strong Financials
No Data
No Data
71875619 : when were you in? when it was falling or rising?